Disclosures for "Cenobamate in Adolescent Patients With Focal Epilepsy: A Phase 1 Pharmacokinetic Study to Determine an Appropriate Dosing Regimen to Optimize Safety, Tolerability, and Efficacy"
-
Vijaykumar Vashi has nothing to disclose.
-
Dr. Krishna has received personal compensation for serving as an employee of SK Life Sciences .
-
The institution of Dr. Jonsson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Company qPharmetra. LLC.
-
Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.